KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1139 |
|---|---|
| Product Name | Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab) |
| Molecular Name | Catumaxomab |
| Alias | Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab |
| CAS Number | 509077-98-9 |
| Molecular Weight | 150.51 kDa |
| Target | CD3E & EpCAM[Homo sapiens] |
| Isotype | IgG2a Kappa/G2b Lambda |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Background | Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in people with metastasizing cancer. It binds to antigens CD3 and EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany). |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
